207 related articles for article (PubMed ID: 30373874)
1. Cutaneous Skeletal Hypophosphatemia Syndrome in Association with a Mosaic
Park PG; Park E; Hyun HS; Kang HG; Ha IS; Cho TJ; Ko JM; Cheong HI
Ann Clin Lab Sci; 2018 Sep; 48(5):665-669. PubMed ID: 30373874
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy.
Lim YH; Ovejero D; Derrick KM; ; Collins MT; Choate KA
J Am Acad Dermatol; 2016 Aug; 75(2):420-7. PubMed ID: 27444071
[TBL] [Abstract][Full Text] [Related]
3. Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
[TBL] [Abstract][Full Text] [Related]
4. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
Groesser L; Herschberger E; Ruetten A; Ruivenkamp C; Lopriore E; Zutt M; Langmann T; Singer S; Klingseisen L; Schneider-Brachert W; Toll A; Real FX; Landthaler M; Hafner C
Nat Genet; 2012 Jun; 44(7):783-7. PubMed ID: 22683711
[TBL] [Abstract][Full Text] [Related]
5. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment with MEK-inhibitor in a patient with NRAS-related cutaneous skeletal hypophosphatemia syndrome.
Carli D; Cardaropoli S; Tessaris D; Coppo P; La Selva R; Cesario C; Lepri FR; Pullano V; Palumbo M; Ramenghi U; Brusco A; Medico E; De Sanctis L; Ferrero GB; Mussa A
Genes Chromosomes Cancer; 2022 Dec; 61(12):740-746. PubMed ID: 35999193
[TBL] [Abstract][Full Text] [Related]
7. Expanding mutational spectrum of HRAS by a patient with Schimmelpenning-Feuerstein-Mims syndrome.
Luo Q; Zhang Q; Shen J; Guan W; Li M; Zhang J; Tan Z
J Dermatol; 2021 Aug; 48(8):1273-1276. PubMed ID: 34109654
[TBL] [Abstract][Full Text] [Related]
8. Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies.
Chacon-Camacho OF; Lopez-Moreno D; Morales-Sanchez MA; Hofmann E; Pacheco-Quito M; Wieland I; Cortes-Gonzalez V; Villanueva-Mendoza C; Zenker M; Zenteno JC
Mol Genet Genomic Med; 2019 May; 7(5):e625. PubMed ID: 30891959
[TBL] [Abstract][Full Text] [Related]
9. A postzygotic KRAS mutation in a patient with Schimmelpenning syndrome presenting with lipomatosis, renovascular hypertension, and diabetes mellitus.
Nagatsuma M; Takasawa K; Yamauchi T; Nakagawa R; Mizuno T; Tanaka E; Yamamoto K; Uemura N; Kashimada K; Morio T
J Hum Genet; 2019 Feb; 64(2):177-181. PubMed ID: 30443000
[TBL] [Abstract][Full Text] [Related]
10. Inguinal lymph nodes agenesia in a patient with Schimmelpenning-Feuerstein-Mims syndrome with proven somatic KRAS mutation.
Blanco Portals C; Gómez Tellado M; Del Pozo Losada J; Rodríguez Ruiz M
Clin Exp Dermatol; 2022 Jan; 47(1):235-239. PubMed ID: 34435383
[TBL] [Abstract][Full Text] [Related]
11. A Patient With Schimmelpenning Syndrome and Mosaic KRAS Mutation.
Mitchell BJ; Rogers GF; Wood BC
J Craniofac Surg; 2019 Jan; 30(1):184-185. PubMed ID: 30394973
[TBL] [Abstract][Full Text] [Related]
12. Mosaic NRAS Q61R mutation in a child with giant congenital melanocytic naevus, epidermal naevus syndrome and hypophosphataemic rickets.
Ramesh R; Shaw N; Miles EK; Richard B; Colmenero I; Moss C
Clin Exp Dermatol; 2017 Jan; 42(1):75-79. PubMed ID: 27900779
[TBL] [Abstract][Full Text] [Related]
13. HRAS-related epidermal nevus syndromes: Expansion of the spectrum with first branchial arch defects.
Beyens A; Lietaer C; Claes K; De Baere E; Goeteyn M; Lerut B; Syryn H; Vanakker O; Van der Meulen J; Vanwalleghem L; Callewaert B
Clin Genet; 2023 Jun; 103(6):709-713. PubMed ID: 36896710
[TBL] [Abstract][Full Text] [Related]
14. Somatic KRAS mutation affecting codon 146 in linear sebaceous nevus syndrome.
Kapoor S; Scanga HL; Reyes-Múgica M; Nischal KK
Am J Med Genet A; 2021 Dec; 185(12):3825-3830. PubMed ID: 34254724
[TBL] [Abstract][Full Text] [Related]
15. Is Schimmelpenning Syndrome Associated with Intracranial Tumors? A Case Report.
Chiang MC; McDowell MM; Weaver K; Broniscer A; Greene S
Pediatr Neurosurg; 2019; 54(3):201-206. PubMed ID: 30879010
[TBL] [Abstract][Full Text] [Related]
16. Schimmelpenning-Feuerstein-Mims syndrome with orbital choristoma and
Yeager LB; Casper DS; Del Portillo A; Marr BP
Ophthalmic Genet; 2023 Dec; ():1-6. PubMed ID: 38097938
[TBL] [Abstract][Full Text] [Related]
17. Systematised naevus sebaceus resulting from post-zygotic mutation in HRAS.
Hsu CK; Saito R; Nanda A; Rashidghamat E; Al-Ajmi H; Lee JY; Hide M; McGrath JA
Australas J Dermatol; 2017 Feb; 58(1):58-60. PubMed ID: 26400620
[TBL] [Abstract][Full Text] [Related]
18. Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.
Lim YH; Ovejero D; Sugarman JS; Deklotz CM; Maruri A; Eichenfield LF; Kelley PK; Jüppner H; Gottschalk M; Tifft CJ; Gafni RI; Boyce AM; Cowen EW; Bhattacharyya N; Guthrie LC; Gahl WA; Golas G; Loring EC; Overton JD; Mane SM; Lifton RP; Levy ML; Collins MT; Choate KA
Hum Mol Genet; 2014 Jan; 23(2):397-407. PubMed ID: 24006476
[TBL] [Abstract][Full Text] [Related]
19. The first case of Chinese phacomatosis pigmentokeratotica diagnosed by a missense HRAS mosaicism.
Huang L; Zhang J; Chen F; Zhang X; Cao Y; Cheng R; Deng D
J Dermatol; 2022 Sep; 49(9):921-924. PubMed ID: 35567308
[TBL] [Abstract][Full Text] [Related]
20. KRAS G12D mosaic mutation in a Chinese linear nevus sebaceous syndrome infant.
Wang H; Qian Y; Wu B; Zhang P; Zhou W
BMC Med Genet; 2015 Oct; 16():101. PubMed ID: 26521233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]